RemeGen Co., Ltd. News

Remegen's announcement regarding the dilutive immediate return and remedial measures for the issuance of A shares to specific parties in 2024 and relevant commitments of the main entities (revised draft)

Jul 25 00:00

Remegen issued a revised announcement regarding the issuance of A shares to specific objects in 2024.

Jul 25 00:00

Remegen announces the adjustment of its 2024 A-share stock issuance plan for specific targets.

Jul 25 00:00

Feasibility analysis report (revised) for the use of funds raised from the issuance of A shares of Remegen in 2024 to specific objects.

Jul 25 00:00

Revised analysis report on Remegen's A-share stock issuance plan for specific targets in 2024.

Jul 25 00:00

Remegen's plan to issue A shares of stocks to specific entities has been revised for the 2024 fiscal year.

Jul 25 00:00

Remegen's announcement on the revised plan to issue A shares of stocks to specific targets in 2024

Jul 25 00:00

Announcement of Progress in Enterprise Shareholding of the Company Controlled by the Actual Controller of Remegen Biopharmaceutical (Yantai) Co., Ltd.

Jul 17 00:00

Announcement of Remegen Pharmaceutical (Yantai) Co., Ltd. regarding the plan of the actual controller to increase shareholding in the company.

Jul 9 00:00

Rongchang Biotech's indicative announcement on the 2024 plan to issue A-shares to specific targets

Mar 30 00:00

Announcement of Rongchang Biotech on the issuance of A shares to specific targets in 2024, diluted immediate returns and compensation measures and commitments from related entities

Mar 30 00:00

Feasibility analysis report on the use of funds raised by Rongchang Biotech by issuing A-shares to specific targets in 2024

Mar 30 00:00

Demonstration analysis report on Rongchang Biotech's 2024 A-share issuance plan to specific targets

Mar 30 00:00

Rongchang Biotech's 2024 plan to issue A-shares to specific targets

Mar 30 00:00

Rongchang Biotech's announcement on the current issuance of A-shares to specific targets will not directly or through stakeholders provide financial support or compensation to investors participating in the subscription

Mar 30 00:00

Rongchang Biotech's shareholder dividend return plan for the next three years (2024-2026)

Mar 30 00:00

Announcement of Rongchang Biopharmaceutical (Yantai) Co., Ltd. on the 2023 profit distribution plan

Mar 28 00:00

Rongchang Biopharmaceutical (Yantai) Co., Ltd. Limited Stock Listing and Circulation Notice

Mar 23 00:00

Announcement of Rongchang Biopharmaceutical (Yantai) Co., Ltd. on the completion of the plan to increase the company\'s shares and the results of the increase in holdings of enterprises controlled by the actual controller

Jan 26 00:00

Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2022 A-share Restricted Stock Incentive Plan Class A Rights First Vesting Period First Vesting Results and Stock Listing Announcement

Jan 23 00:00